A new trend in pathogenetic treatment of rheumatoid arthritis: tofacitinib, the first inhibitor of Janus kinase
The Problem of effective treatment of rheumatoid arthritis (RA) has not been solved yet. In patients with an inadequate response to the synthetic disease-modifying antirheumatic drugs (DMARDs), TNF inhibitors and other genetically engineered (GE) drugs may give an incomplete effect or be totally ine...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2014-03-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/509 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|